FDA Warning Letter — DuPont Nutrition USA, Inc

Case 627211 — FEI 3013947845

The FDA took a Warning Letter action against DuPont Nutrition USA, Inc on December 2, 2022 (Newark, DE). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
DuPont Nutrition USA, Inc
Date
December 2, 2022
Fiscal Year
2023
Product Type
Drugs
Center
CDER
Location
Newark, DE (United States)